92 related articles for article (PubMed ID: 9519350)
1. Left ventricular remodelling and improved long-term outcomes in chronic heart failure.
Sharpe N; Doughty RN
Eur Heart J; 1998 Feb; 19 Suppl B():B36-9. PubMed ID: 9519350
[TBL] [Abstract][Full Text] [Related]
2. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
3. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.
Bristow MR; Gilbert EM; Abraham WT; Adams KF; Fowler MB; Hershberger RE; Kubo SH; Narahara KA; Ingersoll H; Krueger S; Young S; Shusterman N
Circulation; 1996 Dec; 94(11):2807-16. PubMed ID: 8941106
[TBL] [Abstract][Full Text] [Related]
7. Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program.
Gilbert EM
Am J Cardiol; 2004 May; 93(9A):30B-4B. PubMed ID: 15144934
[TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
[TBL] [Abstract][Full Text] [Related]
9. The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.
Bell DS; Lukas MA; Holdbrook FK; Fowler MB
Curr Med Res Opin; 2006 Feb; 22(2):287-96. PubMed ID: 16466600
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.
Packer M; Antonopoulos GV; Berlin JA; Chittams J; Konstam MA; Udelson JE
Am Heart J; 2001 Jun; 141(6):899-907. PubMed ID: 11376302
[TBL] [Abstract][Full Text] [Related]
11. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N
J Card Fail; 2000 Mar; 6(1):11-8. PubMed ID: 10746814
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
[TBL] [Abstract][Full Text] [Related]
14. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
Cleland JG; Charlesworth A; Lubsen J; Swedberg K; Remme WJ; Erhardt L; Di Lenarda A; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson PA;
J Am Coll Cardiol; 2006 Apr; 47(8):1603-11. PubMed ID: 16630997
[TBL] [Abstract][Full Text] [Related]
16. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
Fowler MB
Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
[TBL] [Abstract][Full Text] [Related]
18. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol produces sustained long-term benefits: follow-up at 12 years.
MacGregor JF; Wachter SB; Munger M; Stoddard G; Bristow MR; Gilbert EM
Congest Heart Fail; 2009; 15(1):5-8. PubMed ID: 19187400
[TBL] [Abstract][Full Text] [Related]
20. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
